Literature DB >> 23769649

Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty.

Takumi Inami1, Masaharu Kataoka, Nobuhiko Shimura, Haruhisa Ishiguro, Ryoji Yanagisawa, Hiroki Taguchi, Keiichi Fukuda, Hideaki Yoshino, Toru Satoh.   

Abstract

OBJECTIVES: This study sought to identify useful predictors for hemodynamic improvement and risk of reperfusion pulmonary edema (RPE), a major complication of this procedure.
BACKGROUND: Percutaneous transluminal pulmonary angioplasty (PTPA) has been reported to be effective for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH). PTPA has not been widespread because RPE has not been well predicted.
METHODS: We included 140 consecutive procedures in 54 patients with CTEPH. The flow appearance of the target vessels was graded into 4 groups (Pulmonary Flow Grade), and we proposed PEPSI (Pulmonary Edema Predictive Scoring Index) = (sum total change of Pulmonary Flow Grade scores) × (baseline pulmonary vascular resistance). Correlations between occurrence of RPE and 11 variables, including hemodynamic parameters, number of target vessels, and PEPSI, were analyzed.
RESULTS: Hemodynamic parameters significantly improved after median observation period of 6.4 months, and the sum total changes in Pulmonary Flow Grade scores were significantly correlated with the improvement in hemodynamics. Multivariate analysis revealed that PEPSI was the strongest factor correlated with the occurrence of RPE (p < 0.0001). Receiver-operating characteristic curve analysis demonstrated PEPSI to be a useful marker of the risk of RPE (cutoff value 35.4, negative predictive value 92.3%).
CONCLUSIONS: Pulmonary Flow Grade score is useful in determining therapeutic efficacy, and PEPSI is highly supportive to reduce the risk of RPE after PTPA. Using these 2 indexes, PTPA could become a safe and common therapeutic strategy for CTEPH.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B-type natriuretic peptide; BNP; CI; CO; CTEPH; PAP; PAWP; PEPSI; PTPA; PVR; Pulmonary Edema Predictive Scoring Index; RAP; ROC; RPE; cardiac output; chronic thromboembolic pulmonary hypertension; confidence interval; flow appearance; percutaneous transluminal pulmonary angioplasty; pulmonary arterial pressure; pulmonary artery wedge pressure; pulmonary vascular resistance; receiver-operating characteristic; reperfusion pulmonary edema; right atrial pressure

Mesh:

Year:  2013        PMID: 23769649     DOI: 10.1016/j.jcin.2013.03.009

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  23 in total

1.  Balloon pulmonary angioplasty: applicability of C-Arm CT for procedure guidance.

Authors:  Jan B Hinrichs; Julius Renne; Marius M Hoeper; Karen M Olsson; Frank K Wacker; Bernhard C Meyer
Journal:  Eur Radiol       Date:  2016-02-23       Impact factor: 5.315

Review 2.  [Treatment of acute and chronic right ventricular failure].

Authors:  T Kramm; S Guth; C B Wiedenroth; H A Ghofrani; E Mayer
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-30       Impact factor: 0.840

3.  Chronic thromboembolic pulmonary hypertension: Evaluation of 2D-perfusion angiography in patients who undergo balloon pulmonary angioplasty.

Authors:  Sabine K Maschke; Julius Renne; Thomas Werncke; Karen M Olsson; Marius M Hoeper; Frank K Wacker; Bernhard C Meyer; Jan B Hinrichs
Journal:  Eur Radiol       Date:  2017-03-30       Impact factor: 5.315

Review 4.  Chronic thromboembolic pulmonary hypertension: emerging endovascular therapy.

Authors:  Keshav Menon; Patrick D Sutphin; Sonja Bartolome; Sanjeeva P Kalva; Takeshi Ogo
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

5.  Catheter-Based Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Jane A Leopold
Journal:  Circ Cardiovasc Interv       Date:  2016-10       Impact factor: 6.546

Review 6.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 7.  Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.

Authors:  Timothy M Fernandes; David S Poch; William R Auger
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

Review 8.  Balloon Pulmonary Angioplasty in Patients With Thromboembolic Pulmonary Hypertension.

Authors:  Panagiotis Karyofyllis; Varvara Papadopoulou; Vassilis Voudris; Hiromi Matsubara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-24

9.  C-Arm computed tomography (CACT)-guided balloon pulmonary angioplasty (BPA): Evaluation of patient safety and peri- and post-procedural complications.

Authors:  Sabine K Maschke; Jan B Hinrichs; Julius Renne; Thomas Werncke; Hinrich M B Winther; Kristina I Ringe; Karen M Olsson; Marius M Hoeper; Frank K Wacker; Bernhard C Meyer
Journal:  Eur Radiol       Date:  2018-09-12       Impact factor: 5.315

Review 10.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Amanda Lloji; Urvashi Hooda; Jayakumar Sreenivasan; Ramin Malekan; Wilbert S Aronow; Gregg M Lanier
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.